The pharmacological armamentarium against epilepsy has expanded considerably over the
last three decades, and currently includes over 30 different antiseizure medications. Despite …

Introduction: During the current pandemic, measures for preventing SARS-CoV-2 virus
exposure has severely impacted the delivery of outpatient clinical care to patients with a …

Objective Our epilepsy population recently experienced the acute effects of the COVID‐19
pandemic in New York City. Herein, we aimed to determine patient‐perceived seizure …

The development of mobile health for epilepsy has grown in the last years, bringing new
applications (apps) to the market and improving already existing ones. In this systematic …

Background and Objectives We conducted a multisite, pragmatic replication trial at 4 New
England epilepsy centers to determine the effectiveness of Home-Based Self-Management …

Objective To assess feasibility, patient satisfaction, and financial advantages of telemedicine
for epilepsy ambulatory care during the current COVID-19 pandemic. Methods The …

In the last decade, telemedicine has become more popular, including electronic health
records, illness risk assessments, online consultations, and electronic pharmaceuticals …

Objective Using video-EEG (v-EEG) diagnosis as a gold standard, we assessed the
predictive diagnostic value of home videos of spells with or without additional limited …

Objective To characterize the experience of people with epilepsy and aligned healthcare
workers (HCWs) during the first 18 months of the COVID‐19 pandemic and compare …

Objective Access to epilepsy specialist care is not uniform in the USA, with prominent gaps
in rural areas. Understanding the reasons for nonattendance at epilepsy appointments may …